524715:BOM
Sun Pharmaceutical Industries Ltd
₹ 1.760,00
arrow_downward
-0,03%(-0,60) 1D
16 okt, 15:30:00 GMT+5:30 · INR
search
Alle symbolen
| Symbool | Prijs | Wijziging | Wijzigingspercentage |
|---|
insights_autoBelangrijkste inzichten voor 524715 genereren…
Openen
₹ 1.759,60
Hoog
₹ 1.764,40
Laag
₹ 1.744,85
Beursw.
4,22Â bln.
Gem. vol.
97,37K
Volume
35,68K
Dividend
0,91%
Kwartaaldividend
₹ 4,00
Ex-dividenddatum
7 jul 2026
Koers/winst-verhouding
34,89
52 wk hoog
₹ 2.047,55
52 wk laag
₹ 1.583,60
WPA
₹ 50,44
Uitstaande aandelen
0,00
Aantal medewerkers
47K
Openen
₹ 1.759,60
Hoog
₹ 1.764,40
Laag
₹ 1.744,85
Beursw.
4,22Â bln.
Gem. vol.
97,37K
Volume
35,68K
Dividend
0,91%
Kwartaaldividend
₹ 4,00
Ex-dividenddatum
7 jul 2026
Koers/winst-verhouding
34,89
52 wk hoog
₹ 2.047,55
52 wk laag
₹ 1.583,60
WPA
₹ 50,44
Uitstaande aandelen
0,00
Aantal medewerkers
47K
Nieuwsartikelen
Van webbronnen en nieuwspartners
ad-hoc-news.de
·
9 uur geleden
Sun Pharma stock: Results are due October 29 for Sun Pharma stock
ad-hoc-news.de
·
14 uur geleden
Crisil rates Sun Pharma debt AAA. Sun Pharma stock is valued at INR 4.2 trillion
ad-hoc-news.de
·
1 dag geleden
Analyst consensus puts Sun Pharma stock at INR 2,180.00
Moneycontrol.com
·
2 dagen geleden
Sun Pharma: Tariff relief, innovation brighten growth outlook
Profiel
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world.
Around 70% of Sun Pharma’s revenue is generated from international markets. The US and India are the largest markets, accounting for over 60% of the company's turnover. Manufacturing is across 43 locations in India, the US, Asia, Africa, Australia and Europe. The products cater to therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin. Wikipedia
Over Sun Pharmaceutical Industries Ltd